Powala Christopher 4
4 · Aclaris Therapeutics, Inc. · Filed Dec 18, 2018
Insider Transaction Report
Form 4
Powala Christopher
Chief Operating Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2018-12-15−1,300→ 2,600 total→ Common Stock (1,300 underlying) - Tax Payment
Common Stock
2018-12-15$7.31/sh−357$2,610→ 138,264 total - Exercise/Conversion
Common Stock
2018-12-15+1,300→ 138,621 total
Holdings
- 130,434(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
- [F3]These shares are held by the Christopher V. Powala Aclaris Irrevocable Trust, for which Mr. Powala serves as trustee.
- [F4]On December 15, 2016, the reporting person was granted 10,400 restricted stock units. 50% of the shares underlying these restricted stock units vested on May 7, 2018 upon the achievement of a specified commercial milestone. The other 50% of the shares underlying the restricted stock units vest in four equal annual installments beginning on December 15, 2017, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.